A recent study has shown that a cheap antidepressant drug may help with early COVID-19 cases, stopping the need for hospitalizations among high-risk adults who catch the virus.
The pill is called fluvoxamine and is usually used for depression and obsessive-compulsive disorder. Fluvoxamine is known for reducing inflammation, and in smaller studies, researchers found it provided promising results.
The study, co-authored by Dr. Edward Mills of McMaster University in Ontario, was shared with the U.S. National Institutes of Health. Mills shared that they are hoping for a World Health Organization recommendation.